Literature DB >> 8380814

Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro.

A Cantin1, D E Woods.   

Abstract

Myeloperoxidase, in the presence of noncytotoxic concentrations of H2O2, was used to induce cytotoxicity to the lung epithelial cell line, AKD. When the cationic aminoglycosides, tobramycin and gentamicin were added to the cells in the presence of myeloperoxidase and H2O2, cytotoxicity was completely inhibited. In addition, tobramycin prevented cytotoxicity induced by cystic fibrosis sputum and H2O2. Protection against myeloperoxidase and H2O2 was also observed with the thioether-containing antibiotics, ticarcillin and ceftazidime, but at higher concentrations than with the aminoglycosides. Analysis of spectral properties, dimethylsulfoxide-mediated reduction, and ethyl acetate/NaCl partitioning, demonstrated that aminoglycosides converted HOCl to hydrophilic noncytotoxic chloramines, but were unable to prevent the oxidation of sulfhydryls and methionine by HOCl. In contrast, ticarcillin and ceftazidime were highly effective inhibitors of HOCl-mediated sulfhydryl and methionine oxidation. These results suggest that aminoglycosides protect lung epithelial cells against myeloperoxidase-dependent oxidant injury by binding to anionic cell surfaces and converting HOCl to hydrophilic noncytotoxic chloramines, whereas penicillins and cephalosporins are potent HOCl scavengers capable of protecting critical extracellular molecules against oxidation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380814      PMCID: PMC329992          DOI: 10.1172/JCI116196

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Biologically-significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by some anti-inflammatory drugs.

Authors:  M Wasil; B Halliwell; C P Moorhouse; D C Hutchison; H Baum
Journal:  Biochem Pharmacol       Date:  1987-11-15       Impact factor: 5.858

2.  Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.

Authors:  W Goldstein; G Döring
Journal:  Am Rev Respir Dis       Date:  1986-07

3.  Preparation and characterization of chloramines.

Authors:  E L Thomas; M B Grisham; M M Jefferson
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

4.  Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa.

Authors:  R J Stead; M E Hodson; J C Batten
Journal:  Br J Dis Chest       Date:  1987-07

5.  New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system.

Authors:  R J Johnson; W G Couser; E Y Chi; S Adler; S J Klebanoff
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

6.  Hypochlorite scavenging by Pseudomonas aeruginosa alginate.

Authors:  D B Learn; E P Brestel; S Seetharama
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

7.  Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.

Authors:  A M Cantin; S L North; G A Fells; R C Hubbard; R G Crystal
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

8.  Generation of free radical intermediates from foreign compounds by neutrophil-derived oxidants.

Authors:  B Kalyanaraman; P G Sohnle
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

9.  Isolation and properties of human neutrophil myeloperoxidase.

Authors:  N R Matheson; P S Wong; J Travis
Journal:  Biochemistry       Date:  1981-01-20       Impact factor: 3.162

10.  Biochemical requirements for singlet oxygen production by purified human myeloperoxidase.

Authors:  J R Kanofsky; J Wright; G E Miles-Richardson; A I Tauber
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

View more
  15 in total

1.  Pseudomonas aeruginosa and cystic fibrosis: Antibiotic therapy and the science behind the magic.

Authors:  N E Macdonald
Journal:  Can J Infect Dis       Date:  1997-11

2.  Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection.

Authors:  Moayad Alhariri; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

3.  Oxidant-scavenging activities of beta-lactam agents.

Authors:  R Carreer; G Deby-Dupont; C Deby; L Jadoul; M Mathy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

Review 4.  Cefoperazone prevents the inactivation of alpha(1)-antitrypsin by activated neutrophils.

Authors:  F Dallegri; P Dapino; N Arduino; M Bertolotto; L Ottonello
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

5.  Aminoglycosides as substrates and inhibitors of peroxidases: a possible role of these antibiotics against myeloperoxidase-dependent cytotoxicity.

Authors:  Anita Lorrai; Alessandra Padiglia; Rosaria Medda; Andrea Bellelli; Alessandro Arcovito; Giovanni Floris
Journal:  J Protein Chem       Date:  2002-02

6.  Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity.

Authors:  M Gziut; H J MacGregor; T G Nevell; T Mason; D Laight; J K Shute
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 7.  Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.

Authors:  Susan M Cheer; John Waugh; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  In vitro inhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanism.

Authors:  Luciano Ottonello; Nicoletta Arduino; Maria Bertolotto; Patrizia Dapino; Marina Mancini; Franco Dallegri
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

9.  Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport.

Authors:  A M Cantin
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Ceftazidime improves hemodynamics and oxygenation in ovine smoke inhalation injury and septic shock.

Authors:  Marc O Maybauer; Dirk M Maybauer; John F Fraser; Lillian D Traber; Martin Westphal; Robert A Cox; Ruksana Huda; Yoshimitsu Y Nakano; Perenlei Enkhbaatar; Hal K Hawkins; David N Herndon; Daniel L Traber
Journal:  Intensive Care Med       Date:  2007-05-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.